Takao Shimizu Selected Research

Brain Injuries (Brain Injury)

8/2004	Regulatory mechanism and physiological role of cytosolic phospholipase A2.
8/2002	Roles for cytosolic phospholipase A2alpha as revealed by gene-targeted mice.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Takao Shimizu Research Topics

Disease

27	Inflammation (Inflammations) 01/2022 - 05/2002
9	Pain (Aches) 01/2024 - 07/2004
8	Neoplasms (Cancer) 06/2022 - 02/2003
7	Asthma (Bronchial Asthma) 02/2024 - 01/2002
6	Hepatocellular Carcinoma (Hepatoma) 09/2020 - 12/2018
6	Fibrosis (Cirrhosis) 12/2019 - 05/2006
6	Hypersensitivity (Allergy) 03/2012 - 10/2005
6	Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental) 04/2010 - 09/2005
5	Anaphylaxis (Anaphylactic Shock) 01/2021 - 08/2002
5	Obesity 01/2019 - 06/2003
5	Bone Resorption 12/2009 - 05/2003
4	Neuralgia (Stump Neuralgia) 04/2024 - 05/2010
4	Ischemia 08/2013 - 08/2002
3	Psoriasis (Pustulosis Palmaris et Plantaris) 01/2023 - 10/2004
3	Peripheral Nerve Injuries 01/2022 - 10/2008
3	Chronic Hepatitis C 05/2020 - 12/2018
3	Leukemia 01/2018 - 11/2002
3	Hemorrhage 11/2013 - 08/2002
3	Reperfusion Injury 08/2013 - 06/2003
3	Multiple Sclerosis 12/2009 - 10/2008
3	Pulmonary Fibrosis (Fibrosing Alveolitis) 12/2009 - 05/2002
3	Respiratory Hypersensitivity 10/2005 - 01/2002
2	Hyperalgesia 04/2024 - 05/2010
2	Chronic Pain 04/2024 - 05/2010
2	Emphysema 02/2024 - 08/2022
2	Chronic Obstructive Pulmonary Disease (COPD) 02/2024 - 08/2022
2	Fever (Fevers) 01/2024 - 01/2015
2	Immune System Diseases (Immune Disorders) 01/2023 - 10/2005
2	Infections 11/2019 - 01/2019
2	Malaria 07/2019 - 06/2004
2	Ureteral Obstruction 01/2019 - 01/2019
2	Alzheimer Disease (Alzheimer's Disease) 01/2019 - 01/2019
2	Lung Injury 12/2017 - 05/2003
2	Acute Lung Injury 08/2014 - 08/2002
2	Insulin Resistance 04/2010 - 06/2003
2	Idiopathic Pulmonary Fibrosis 12/2009 - 05/2002
2	Rheumatoid Arthritis 03/2008 - 10/2004
2	Osteoporosis 03/2008 - 07/2004
2	Pneumococcal Pneumonia 01/2006 - 02/2004
2	Lissencephaly 11/2005 - 08/2003
2	Brain Injuries (Brain Injury) 08/2004 - 08/2002

Drug/Important Bio-Agent (IBA)

20	LipidsIBA 04/2024 - 07/2003
15	Platelet Activating FactorIBA 04/2024 - 01/2002
15	EnzymesIBA 04/2024 - 05/2002
13	Leukotriene B4IBA 01/2022 - 08/2002
13	Phospholipases (Phospholipase)IBA 01/2015 - 05/2002
13	platelet activating factor receptorIBA 09/2013 - 01/2002
10	Proteins (Proteins, Gene)FDA Link 12/2021 - 11/2005
9	Leukotriene B4 Receptors (Leukotriene B4 Receptor)IBA 01/2019 - 10/2005
7	G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA 01/2023 - 10/2004
7	CytokinesIBA 01/2022 - 05/2003
6	Phospholipids (Phosphatides)FDA LinkGeneric 01/2024 - 06/2002
6	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 06/2014 - 06/2003
5	1-Acylglycerophosphocholine O-Acyltransferase (1 Acylglycerophosphocholine O Acyltransferase)IBA 02/2024 - 01/2017
4	Fatty Acids (Saturated Fatty Acids)IBA 01/2022 - 01/2019
4	Antiviral Agents (Antivirals)IBA 05/2020 - 12/2018
4	CollagenIBA 01/2019 - 05/2002
4	Arachidonic Acid (Vitamin F)IBA 10/2012 - 07/2010
4	Immunoglobulin G (IgG)IBA 05/2012 - 04/2008
4	EicosanoidsIBA 12/2011 - 05/2002
4	Prostaglandins EIBA 07/2010 - 05/2003
3	lysophosphatidic acidIBA 01/2023 - 01/2017
3	wisteria lectinIBA 05/2020 - 12/2018
3	Carrier Proteins (Binding Protein)IBA 05/2020 - 12/2018
3	Glucose (Dextrose)FDA LinkGeneric 01/2018 - 06/2003
3	LipopolysaccharidesIBA 01/2015 - 05/2003
3	Dinoprostone (PGE2)FDA Link 01/2015 - 05/2003
3	Group IV Phospholipases A2IBA 10/2012 - 09/2005
3	ProstaglandinsIBA 12/2009 - 05/2003
2	SmokeIBA 02/2024 - 08/2022
2	Biomarkers (Surrogate Marker)IBA 01/2024 - 01/2019
2	MetalsIBA 03/2023 - 01/2023
2	Chromogranin AIBA 06/2022 - 01/2014
2	glyceryl 2-arachidonate (2-arachidonoylglycerol)IBA 01/2019 - 01/2015
2	CB1 Cannabinoid Receptor (CB1 Receptor)IBA 01/2019 - 01/2015
2	Monoacylglycerol LipasesIBA 01/2019 - 01/2015
2	EndocannabinoidsIBA 01/2019 - 01/2015
2	LeukotrienesIBA 01/2018 - 03/2008
2	Triglycerides (Triacylglycerol)IBA 01/2017 - 09/2009
2	Polychlorinated Dibenzodioxins (TCDD)IBA 01/2017 - 02/2014
2	Formaldehyde (Formol)FDA Link 03/2015 - 09/2007
2	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 06/2014 - 02/2010
2	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 02/2014 - 02/2010
2	Immunoglobulin E (IgE)IBA 03/2012 - 04/2008
2	IgG Receptors (Fc gamma RI)IBA 03/2012 - 04/2011
2	Phospholipases A2 (Phospholipase A2)IBA 12/2011 - 05/2003
2	Small Interfering RNA (siRNA)IBA 10/2010 - 07/2010
2	AdiponectinIBA 04/2010 - 06/2003
2	indium-bleomycinIBA 12/2009 - 05/2002
2	Bleomycin (Blenoxane)FDA LinkGeneric 12/2009 - 05/2002
2	oxidized low density lipoproteinIBA 01/2008 - 10/2004
2	Cholinergic Agents (Cholinergics)IBA 06/2004 - 01/2002

Therapy/Procedure

8	Therapeutics 01/2023 - 12/2009
3	Pancreaticoduodenectomy 11/2014 - 11/2013
2	Self Expandable Metallic Stents 03/2023 - 01/2023
2	Stents 01/2023 - 11/2014
2	Laparotomy 06/2022 - 02/2003
2	Ligation 01/2017 - 09/2008
2	Drug Therapy (Chemotherapy) 11/2012 - 04/2005
2	Ovariectomy (Oophorectomy) 12/2009 - 07/2004